Medisca Expands Strategic Partnerships to Drive Patient Access to Critical Medications
27.7.2023 14:55:00 EEST | Business Wire | Press release
Medisca has announced the expansion of a network of strategic partnerships aimed at securing and stabilizing worldwide access to high quality active pharmaceutical ingredients (APIs) for the preparation of essential medications. This mission started with the exclusive partnership for Thyroid USP in 2021, and has now expanded to include Progesterone USP (Special Micronized), Testosterone USP (Micronized), Diclofenac Sodium USP, and Ketamine Hydrochloride USP.
In recent years, Medisca has seen significant increases in the demand for these APIs with commercial drug shortages and the need for qualified products and transparency documented as the primary causes. By actively engaging in strategic partnerships, Medisca reinforces its position as a true Partner In Wellness and driver in securing high-quality product supply for the pharmaceutical compounding and healthcare industries.
“We are steadfast in our commitment to promoting pharmaceutical compounding as a legitimate, effective, and essential solution for healthcare providers working to overcome challenges in medication accessibility and looking to provide transformative options for personalized patient care,“ said Panagiota Danopoulos, Senior Vice President of Global Strategy & Innovation at Medisca. “To achieve this we continue our mission to forge partnerships with leaders in API manufacturing that are unified by a common commitment to quality, consistency, and value,” continued Danopoulos
In order to vet the right partners, Medisca conducts thorough due diligence to ensure the highest quality measures are met at the source. All partners undergo a rigorous vendor qualification program with proof of FDA registration, quality agreements in place, and testing performed to verify the quality of the product including, full USP compendial testing, elemental impurity testing, residual solvent testing, and particle size testing for micronized products.
Leveraging these strong partnerships in API manufacturing and collaborating closely with government authorities, Medisca is able to support market access to essential APIs and address the critical needs of healthcare providers and patients across the globe.
About Medisca
Medisca is a global corporation with locations throughout North America, Australia, and Europe, that contributes to healthcare by leveraging strong partnerships that deliver customized solutions with an unwavering commitment to quality and innovation. Backed by 30+ years and a strong foundation in pharmaceutical compounding supply, Medisca is a business-to-business company that delivers comprehensive offerings by providing value, consistency, responsiveness, and loyalty. As Partners in Wellness, Medisca offers an unfailing devotion to improving lives across a multitude of needs and people. For more information visit www.medisca.com and follow us on LinkedIn, Facebook, Twitter, and YouTube.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230727308061/en/
Contact information
Gayle Padvaiskas
Vice President, Global Marketing
Medisca
gpadvaiskas@medisca.com
1-800-665-6334
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Robbyant Upgrades and Open-Sources LingBot-VLA 2.0 as a Next-Generation Universal Brain for Embodied AI8.7.2026 11:11:00 EEST | Press release
Robbyant, an embodied AI company within Ant Group, today announced the upgrade and open-source release of LingBot-VLA 2.0. Building upon the foundation of LingBot-VLA 1.0 released in January 2026, this next-generation vision-language-action (VLA) model delivers significant leaps in morphological generalization, degrees of freedom (DoF) support, and deployment efficiency, delivering a more advanced “universal brain” for scalable real-world robotics. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260707394646/en/ LingBot-VLA 2.0 supports a wide range of robot morphologies While the embodied AI industry is witnessing rapid advancements in hardware and control systems, the lack of a truly universal brain remains a primary bottleneck for industrial-scale deployment. LingBot-VLA 2.0 addresses this critical gap by dramatically expanding its pre-training data and architectural capabilities. LingBot-VLA 2.0 was pre-trained on 60,000
TetraMem and SK hynix Showcase Successful Technology Collaboration Advancing Memory-Centric AI Computing8.7.2026 11:06:00 EEST | Press release
TetraMem Inc., a leader in Analog In-Memory Computing (A-IMC) technology, and SK hynix Inc., a global leader in AI memory and semiconductor technologies, today announced the successful completion of a joint technology collaboration, highlighted by the publication of their research paper, “A Memristor-based In-Memory Computing SoC with Efficient Depthwise Convolution,” in Advanced Intelligent Systems. The work has also been selected as the cover feature of the journal, recognizing its technical innovation and potential impact on next-generation AI computing. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708244132/en/ The collaboration brings together SK hynix’s expertise in advanced memory technologies and TetraMem's Analog In-Memory Computing platform to explore new computing architectures capable of addressing one of artificial intelligence's most pressing challenges: reducing the energy consumption and thermal limitati
NetApp Named Presenting Partner of 2026 NFL Madrid Game8.7.2026 11:00:00 EEST | Press release
The NFL today announced that the league’s Global Partner, NetApp (NASDAQ: NTAP), the Intelligent Data Infrastructure company, will return as Presenting Partner of the 2026 NFL Madrid Game, featuring the Atlanta Falcons taking on the Cincinnati Bengals at the Bernabéu Stadium — home to Real Madrid C.F. — on Sunday, Nov. 8. The multi-year announcement builds on NetApp’s role as the league’s Official Intelligent Data Infrastructure Partner and Presenting Partner of the inaugural NFL Madrid Game in 2025 and continues the company’s support of the league’s international games. “We are delighted to welcome NetApp back as Presenting Partner of the NFL Madrid Game,” said Rafa De Los Santos, country manager of NFL Spain. “Last year’s game at the Bernabéu was a landmark moment for the NFL in Spain, and with the Falcons and Bengals bringing two of the most exciting teams in football to Madrid this November, we look forward to working with NetApp to deliver another unforgettable experience for our
Vultr and SUSE Launch Validated Full-Stack NVIDIA Enterprise AI Platform to Accelerate Production Deployments8.7.2026 11:00:00 EEST | Press release
Vultr, the world's largest privately-held cloud infrastructure company, today announced the launch of SUSE AI Factory with NVIDIA on Vultr infrastructure, developed in partnership with SUSE. Announced alongside SUSE at the RAISE Summit in Paris, this validated, full-stack enterprise AI platform combines enterprise-grade AI software, advanced GPU acceleration, and global AI infrastructure into a single, production-ready solution. As organizations look to move AI workloads from experimentation into production, this joint solution eliminates the complexity of building AI stacks from scratch, allowing enterprises to deploy secure, scalable AI applications with ease. The solution combines software and infrastructure capabilities to help organizations securely and reliably advance applications from sandbox development to global production. Built on an open, Kubernetes-based architecture, the solution supports deployment across cloud, on-premises, edge and sovereign environments. The architec
MSIG Europe Selects Clearwater Analytics to Modernize Investment Operations8.7.2026 11:00:00 EEST | Press release
Clearwater Analytics today announced that MSIG Europe, a wholly owned subsidiary of MS&AD Insurance Group, has selected the Clearwater platform to modernize its operating model, unify data across the investment lifecycle, and meet the demands of the European regulatory environment, including Belgian GAAP, IFRS and Solvency II. European insurers are navigating the convergence of tightening regulatory demands, growing allocations to private markets, and the operational limits of fragmented legacy systems. The firms moving fastest are consolidating onto platforms that deliver daily accuracy, compliance automation, and integrated analytics at scale. MSIG is a wholly-owned subsidiary of Mitsui Sumitomo Insurance and a member of the MS&AD Insurance Group, one of Asia’s leading non-life insurance brands with a presence in 50 countries and regions globally. MSIG’s Asia office along with many of the business units have already successfully implemented Clearwater. MSIG Europe will now use Clearw
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom